首页 > 市场调查报告书 > 製药

脑啡??抑制剂市场:各药物类型，各适应症，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

市场调查报告书

商品编码

1349858

脑啡??抑制剂市场:各药物类型，各适应症，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

Anti-Neprilysin Market, By Drug Type, By Indication, By Distribution Channel, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月03日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球脑啡??抑制剂市值将达到 12.633 亿美元，预测期内（2023-2030 年）复合年增长率为 4.6%。

报告范围		报告详细资料
基准年	2022	2023 年市场规模	美国：12.633亿美元
过去的资料	2018年至2021年	预测期间	2023-2030
预测 2023-2030 年复合年增长率：	4.60%	2030年价值预测	美国：17.365亿美元

脑啡??抑制剂主要用于急性心臟衰竭、癌症疼痛、高血压、阿兹海默症等。最常用的脑啡??抑制剂是沙库巴曲/缬沙坦，以 Entrest 品牌出售。该药由脑啡??抑制剂沙库巴曲和血管紧张素受体拮抗剂缬沙坦组成。Entrest 首先由生物製药公司诺华国际公司生产。这种药物降低了心血管死亡率和心臟衰竭促使的住院率。由于心臟衰竭盛行率不断上升，美国食品药物管理局于 2015 年授予 Entrest 快速通道资格。这将支持 FDA 加速治疗严重和危及生命的疾病的药物的开发和审查，并满足患者未满足的医疗需求。

市场动态

急性心臟衰竭盛行率的增加预计将推动预测期内脑啡??抑制剂市场的成长。例如，根据生物资料库和医学报告免费搜寻引擎 PubMed 2020 年 9 月发布的数据，心臟衰竭每年影响全球超过 6,400 万人。试图减轻其社会和经济负担已成为全球公共卫生的一个主要优先事项。

本调查的主要特征

本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球脑啡??抑制剂市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球脑啡??抑制剂市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球脑啡??抑制剂市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球脑啡??抑制剂市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,263.3 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.60%	2030 Value Projection:	US$ 1,736.5 Mn

Anti-neprilysin drugs are mostly used for acute heart failure, cancer pain, hypertension, Alzheimer's disease, and other diseases. The most commonly used anti-neprilysin is Sacubitril/valsartan thatis sold under the brand name Entrest. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan. Entrest was first manufactured by Novartis International AG- a biopharmaceutical compay. This drug has reduced rate of cardiovascular deaths and hospitalizations related to heart failure. Due to increasing prevalence of heart failure, the U.S. Food And Drug Administration granted fast track designation to Entresto in 2015, which supports the FDA's efforts to facilitate the development and expedite the review of drugs to treat serious or life-threatening conditions and meet the unmet medical needs of patients.

Market Dynamics

Increasing prevalence of acute heart failure is expected to drive the antineprilysin market growth over the forecast period. For instance, according to the data published in September 2020, by PubMed, a free search engine for biological databases and medical reports, Heart failure affects more than 64 million people every year worldwide. Attempts to decrease its social and economic burden have become a major global public health priority.

Key features of the study:

This report provides an in-depth analysis of the global anti-neprilysin market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti-neprilysin market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include BIOPROJET, Novartis AG, Pharmaleads SA, Theravance Biopharm, Cipla Inc, Oceanic Pharmachem Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global anti-neprilysin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-neprilysin market

Detailed Segmentation:

Global Anti-Neprilysin Market, By Drug Type:
- Sacubitril
- TD-0714
- STR-324
- PL-265
- LHW-090
Global Anti-Neprilysin Market, By Indication:
- Acute Heart Failure
- Cancer Pain
- Hypertension
- Alzheimer's Disease
- Others
Global Anti-Neprilysin Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anti-Neprilysin Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- BIOPROJET
- Novartis AG
- Pharmaleads SA
- Theravance Biopharm
- Cipla Inc
- Oceanic Pharmachem Pvt. Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Anti-Neprilysin Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Ant- Neprilysin Market, By Drug Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Sacubitril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
TD-0714
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
STR-324
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
PL-265
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
LHW-090
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Anti-Neprilysin Market, By Indication, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Cancer Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Anti-Neprilysin Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Anti-Neprilysin Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018- 2030, (US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

BIOPROJET
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pharmaleads SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Theravance Biopharm
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cipla Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Oceanic Pharmachem Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

脑啡??抑制剂市场:各药物类型，各适应症，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

Anti-Neprilysin Market, By Drug Type, By Indication, By Distribution Channel, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市场动态

本调查的主要特征

目录

第1章调查目的与前提条件

第2章市场概况

第3章市场动态，法规，趋势分析

第4章脑啡??抑制剂的全球市场-COVID-19影响分析

第5章脑啡??抑制剂的全球市场:各药物类型，2018-2030年

第6章脑啡??抑制剂的全球市场:各适应症，2018年～2030年

第7章脑啡??抑制剂的全球市场:各流通管道，2018年～2030年

第8章脑啡??抑制剂的全球市场:各地区，2018年～2030年

第9章竞争情形

第10章章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Anti-Neprilysin Market- COVID-19 Impact Analysis

5. Global Ant- Neprilysin Market, By Drug Type, 2018-2030, (US$ Mn)

6. Global Anti-Neprilysin Market, By Indication, 2018-2030, (US$ Mn)

7. Global Anti-Neprilysin Market, By Distribution Channel, 2018-2030, (US$ Mn)

8. Global Anti-Neprilysin Market, By Region, 2018-2030, (US$ Mn)

9. Competitive Landscape

10. Section

脑啡??抑制剂市场:各药物类型，各适应症，各流通管道，各地区-规模，占有率，展望，机会分析，2023年～2030年

Anti-Neprilysin Market, By Drug Type, By Indication, By Distribution Channel, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)-Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

市场动态

本调查的主要特征

目录

第1章 调查目的与前提条件

第2章 市场概况

第3章 市场动态，法规，趋势分析

第4章 脑啡??抑制剂的全球市场-COVID-19影响分析

第5章 脑啡??抑制剂的全球市场:各药物类型，2018-2030年

第6章 脑啡??抑制剂的全球市场:各适应症，2018年～2030年

第7章 脑啡??抑制剂的全球市场:各流通管道，2018年～2030年

第8章 脑啡??抑制剂的全球市场:各地区，2018年～2030年

第9章 竞争情形

第10章 章节

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Anti-Neprilysin Market- COVID-19 Impact Analysis

5. Global Ant- Neprilysin Market, By Drug Type, 2018-2030, (US$ Mn)

6. Global Anti-Neprilysin Market, By Indication, 2018-2030, (US$ Mn)

7. Global Anti-Neprilysin Market, By Distribution Channel, 2018-2030, (US$ Mn)

8. Global Anti-Neprilysin Market, By Region, 2018-2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章调查目的与前提条件

第2章市场概况

第3章市场动态，法规，趋势分析

第4章脑啡??抑制剂的全球市场-COVID-19影响分析

第5章脑啡??抑制剂的全球市场:各药物类型，2018-2030年

第6章脑啡??抑制剂的全球市场:各适应症，2018年～2030年

第7章脑啡??抑制剂的全球市场:各流通管道，2018年～2030年

第8章脑啡??抑制剂的全球市场:各地区，2018年～2030年

第9章竞争情形

第10章章节